Clinical Trial Update: Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs [Phase 4]

View source ↗

Summary

Phase 4 trial update on a fourth dose of an mRNA COVID-19 vaccine in residents of long-term care facilities.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• mRNA COVID-19 vaccine

Snippet

Sponsor: Mark Loeb | Conditions: SARS-CoV2 Infection, Coronavirus Infection | Phase 4 | Status: UNKNOWN